Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study
Top Cited Papers
- 1 July 2005
- journal article
- Published by Elsevier in The Lancet
- Vol. 366 (9483), 378-384
- https://doi.org/10.1016/s0140-6736(05)67022-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A Structural Approach to Selection BiasEpidemiology, 2004
- Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapyBMJ, 2002
- Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized TreatmentsJournal of the American Statistical Association, 2001
- Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive MenEpidemiology, 2000
- Human Immunodeficiency Virus Type 1 RNA Level and CD4 Count as Prognostic Markers and Surrogate End Points: A Meta-AnalysisAIDS Research and Human Retroviruses, 2000
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999
- CD4 cell count as a surrogate endpoint in HIV clinical trialsAIDS, 1998
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristicsInternational Journal of Public Health, 1994